Skip to main content
Signal8

Dombkowski Ashley L.

SEC insider (Form 3/4/5 filer). CIK 0001270774. Director at RAPT Therapeutics, Inc. (RAPT). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 3, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Dombkowski Ashley L. has filed insider reports for

  • RAPT Therapeutics, Inc. (RAPT): Director
Dombkowski Ashley L. profile photo

Dombkowski Ashley L.

CIK: 0001270774

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RAPT Therapeutics, Inc. logo
RAPT

RAPT Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • RAPT Therapeutics, Inc. logo
    RAPT

    RAPT Therapeutics, Inc.

    Mar 3, 2026
    Tender Offer
    Direct
    5K shares-
  • RAPT Therapeutics, Inc. logo
    RAPT

    RAPT Therapeutics, Inc.

    Mar 3, 2026
    Disposition

    Director Stock Option (right to buy)

    Direct
    25K shares-
  • RAPT Therapeutics, Inc. logo
    RAPT

    RAPT Therapeutics, Inc.

    Jan 30, 2026
    Award
    Direct
    5K shares-
  • RAPT Therapeutics, Inc. logo
    RAPT

    RAPT Therapeutics, Inc.

    Jun 21, 2025
    Award

    Director Stock Option (right to buy)

    Direct
    25K shares-

1-4 of 4